Hyundai Bioscience Company Description

Hyundai Bioscience Co., Ltd. operates as a biotechnology company.

The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19.

The company was founded in 2000 and is based in Seoul, South Korea.

Hyundai Bioscience Co., Ltd.

Country	South Korea
Founded	2000
Industry	Medical - Pharmaceuticals
Sector	Healthcare
Employees	54

Contact Details

Address: 150, Bugahyeon-ro Seoul, Gyeongsangbuk-do 03759 South Korea
Phone	82 1 544 3194
Website	hyundaibioscience.com

Stock Details

Ticker Symbol	048410
Exchange	KOSDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	KRW
ISIN Number	KR7048410005
SIC Code	2844